Support PenkeNEWRON PHARMACEUT. EO-20 - Trending symbols
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Overbought | Overbought RSI (Relative Strength Index) | 2025-09-18 |
Trends
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Retained Earnings | -26,157 | 6,041 | -20,116 | -2,689 | -22,805 | 1,409 | -21,396 | 32,061 | 10,665 | |
| Income before Tax | -19,618 | 4,734 | -14,884 | -2,588 | -17,472 | 1,272 | -16,200 | 37,594 | 21,394 | |
| Net Income | -20,998 | 6,097 | -14,901 | -2,592 | -17,493 | 1,269 | -16,224 | 32,067 | 15,843 | |
| EBIT | -18,213 | 5,694 | -12,519 | -1,006 | -13,525 | 1,493 | -12,032 | 37,779 | 25,747 | |
| EBITDA | -17,994 | 5,684 | -12,310 | -1,013 | -13,323 | 1,492 | -11,831 | 37,770 | 25,939 | |
| Operating Income | -18,066 | 5,709 | -12,357 | -945 | -13,302 | 1,673 | -11,629 | 37,802 | 26,173 | |
| Net Income from Continuing Operations | -20,998 | 6,097 | -14,901 | -2,592 | -17,493 | 1,269 | -16,224 | 32,067 | 15,843 | |
| Other Stockholders Equity | 46,306 | -20,207 | 26,099 | -20,998 | 5,101 | -5,101 | 0 | -12,081 | -12,081 | |
| Net Working Capital | 54,351 | -23,369 | 30,982 | 4,791 | 35,773 | -12,321 | 23,452 | -32,726 | -9,274 | |
| Current Deferred Revenue | -60 | -91 | -151 | 1 | -150 | -22 | -172 | 186 | 14 | |
| Inventory | 0 | 846 | 846 | -842 | 4 | -4 | 0 | -3 | -3 | |
| Long-term Assets Other | -272 | -473 | -745 | 166 | -579 | 52 | -527 | 6,336 | 5,809 | |
| Other Current Assets | 15,659 | -14,337 | 1,322 | -1,300 | 22 | 760 | 782 | -783 | -1 | |
| Total Stockholder Equity | 54,844 | -18,046 | 36,798 | -19,552 | 17,246 | -14,139 | 3,107 | -17,137 | -14,030 | |
| Depreciation and Amortization | 47 | 1,469 | 1,516 | -610 | 906 | -306 | 600 | -621 | -21 |
Comments
How you think about this?